GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Asset Impairment Charge

DT&CRO Co (XKRX:383930) Asset Impairment Charge : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Asset Impairment Charge?

DT&CRO Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.


DT&CRO Co Asset Impairment Charge Historical Data

The historical data trend for DT&CRO Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Asset Impairment Charge Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
- - - -

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DT&CRO Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


DT&CRO Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines